SYDNEY (Reuters) - An Australian biotechnology firm said on Thursday it had developed a means of delivering anti-cancer drugs directly to cancer cells, which aims to avoid the debilitating toxicity associated with chemotherapy.The method uses nanotechnology, which involves micro-machines far smaller than a human cell.>>> Discuss This Story
